Lung cancer incidence and mortality rates

Figure 8.5

Incidence and mortality rates^† for lung cancer, by sex, Canada — from 1992 to 2014

Download & Export
Figure
Data Table
- CSV
- Excel
- Json
- XML

^† Age-standardized to 2011 Canadian population.

QC: Cancer incidence data not available for 2011, 2012 and 2013 diagnosis years. The 2010 Quebec data have been copied forward into 2011, 2012 and 2013.

Data source: Statistics Canada, Vital Statistics Death Database, Canadian Cancer Registry (CANSIM).

Data Table

Year	Measure	Sex	Age-standardized incidence rate (per 100,000 population)	Lower bound of 95% confidence interval	Upper bound of 95% confidence interval
1992	Incidence	Male	121.4	119.1	123.7
1992	Incidence	Female	52.8	51.5	54.2
1993	Incidence	Male	122.3	120.0	124.6
1993	Incidence	Female	54.0	52.7	55.4
1994	Incidence	Male	115.7	113.5	117.9
1994	Incidence	Female	52.8	51.5	54.1
1995	Incidence	Male	113.2	111.1	115.4
1995	Incidence	Female	54.1	52.8	55.4
1996	Incidence	Male	110.4	108.3	112.4
1996	Incidence	Female	55.8	54.5	57.1
1997	Incidence	Male	106.7	104.7	108.7
1997	Incidence	Female	56.0	54.7	57.3
1998	Incidence	Male	108.0	106.0	110.0
1998	Incidence	Female	57.9	56.6	59.2
1999	Incidence	Male	107.1	105.2	109.1
1999	Incidence	Female	57.9	56.6	59.2
2000	Incidence	Male	102.3	100.4	104.3
2000	Incidence	Female	59.8	58.5	61.0
2001	Incidence	Male	102.5	100.6	104.4
2001	Incidence	Female	59.6	58.3	60.9
2002	Incidence	Male	99.3	97.5	101.2
2002	Incidence	Female	60.4	59.1	61.7
2003	Incidence	Male	96.3	94.5	98.1
2003	Incidence	Female	60.4	59.2	61.7
2004	Incidence	Male	96.4	94.6	98.1
2004	Incidence	Female	61.3	60.1	62.6
2005	Incidence	Male	94.9	93.2	96.6
2005	Incidence	Female	63.1	61.9	64.4
2006	Incidence	Male	93.0	91.4	94.7
2006	Incidence	Female	63.5	62.3	64.8
2007	Incidence	Male	92.6	90.9	94.2
2007	Incidence	Female	63.8	62.5	65.0
2008	Incidence	Male	88.8	87.2	90.4
2008	Incidence	Female	63.9	62.7	65.1
2009	Incidence	Male	87.4	85.9	89.0
2009	Incidence	Female	63.7	62.5	64.9
2010	Incidence	Male	83.5	82.0	85.0
2010	Incidence	Female	61.7	60.6	62.9
2011	Incidence	Male	81.3	79.9	82.7
2011	Incidence	Female	61.4	60.2	62.5
2012	Incidence	Male	81.1	79.7	82.5
2012	Incidence	Female	62.4	61.2	63.5
2013	Incidence	Male	79.4	78.0	80.8
2013	Incidence	Female	62.1	61.0	63.3
1992	Mortality	Male	103.8	101.6	105.9
1992	Mortality	Female	39.4	38.2	40.5
1993	Mortality	Male	104.2	102.1	106.3
1993	Mortality	Female	41.9	40.8	43.1
1994	Mortality	Male	100.7	98.7	102.8
1994	Mortality	Female	42.2	41.1	43.4
1995	Mortality	Male	97.8	95.8	99.9
1995	Mortality	Female	41.4	40.3	42.6
1996	Mortality	Male	97.5	95.5	99.5
1996	Mortality	Female	44.5	43.3	45.7
1997	Mortality	Male	93.7	91.8	95.6
1997	Mortality	Female	42.9	41.8	44.0
1998	Mortality	Male	94.0	92.1	95.9
1998	Mortality	Female	45.7	44.6	46.9
1999	Mortality	Male	94.3	92.4	96.2
1999	Mortality	Female	46.3	45.1	47.4
2000	Mortality	Male	86.1	84.3	87.9
2000	Mortality	Female	45.7	44.6	46.8
2001	Mortality	Male	86.7	85.0	88.5
2001	Mortality	Female	45.5	44.4	46.6
2002	Mortality	Male	86.8	85.1	88.6
2002	Mortality	Female	46.9	45.8	48.0
2003	Mortality	Male	84.4	82.7	86.1
2003	Mortality	Female	46.9	45.8	48.0
2004	Mortality	Male	81.3	79.7	83.0
2004	Mortality	Female	48.0	47.0	49.2
2005	Mortality	Male	80.5	78.9	82.1
2005	Mortality	Female	47.5	46.5	48.6
2006	Mortality	Male	77.9	76.4	79.4
2006	Mortality	Female	48.8	47.7	49.9
2007	Mortality	Male	77.1	75.6	78.6
2007	Mortality	Female	48.2	47.2	49.3
2008	Mortality	Male	74.2	72.7	75.7
2008	Mortality	Female	48.4	47.3	49.4
2009	Mortality	Male	73.7	72.2	75.1
2009	Mortality	Female	48.1	47.1	49.2
2010	Mortality	Male	71.1	69.8	72.5
2010	Mortality	Female	48.2	47.2	49.2
2011	Mortality	Male	69.2	67.9	70.6
2011	Mortality	Female	46.7	45.7	47.7
2012	Mortality	Male	67.8	66.6	69.2
2012	Mortality	Female	46.7	45.8	47.7
2013	Mortality	Male	63.7	62.5	64.9
2013	Mortality	Female	46.5	45.5	47.4
2014	Mortality	Male	64.6	63.4	65.9
2014	Mortality	Female	46.2	45.3	47.2

+ Expand Table

Figure 8.8

Incidence rates for lung cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

Download & Export
Figure
Data Table
- CSV
- Excel
- Json
- XML

"– " Data not available.

Provincial cancer agencies and programs.

Data Table

Jurisdiction	Stage at Diagnosis	Age-standardized incidence (rate per 100,000 women)
BC	Stage I	13.3
BC	Stage II	6.2
BC	Stage III	16.7
BC	Stage IV	38
AB	Stage I	16.5
AB	Stage II	7.3
AB	Stage III	13.3
AB	Stage IV	39.7
SK	Stage I	13.9
SK	Stage II	6.7
SK	Stage III	13.9
SK	Stage IV	45
MB	Stage I	20.7
MB	Stage II	7.3
MB	Stage III	18.7
MB	Stage IV	41.2
ON	Stage I	17.3
ON	Stage II	6.3
ON	Stage III	13.6
ON	Stage IV	32.8
QC	Stage I	–
QC	Stage II	–
QC	Stage III	–
QC	Stage IV	–
NB	Stage I	27
NB	Stage II	8
NB	Stage III	20
NB	Stage IV	40
NS	Stage I	24.2
NS	Stage II	8.9
NS	Stage III	18.7
NS	Stage IV	49.2
PE	Stage I	17.8
PE	Stage II	6.9
PE	Stage III	28.1
PE	Stage IV	43.3
NL	Stage I	21.1
NL	Stage II	6.6
NL	Stage III	16.2
NL	Stage IV	42.8
YT	Stage I	–
YT	Stage II	–
YT	Stage III	–
YT	Stage IV	–
NT	Stage I	–
NT	Stage II	–
NT	Stage III	–
NT	Stage IV	–
NU	Stage I	–
NU	Stage II	–
NU	Stage III	–
NU	Stage IV	–

+ Expand Table

"– " Data not available.

Provincial cancer agencies and programs.

Data specifications
Data specifications
Cancer deaths

Definition: Age-standardized mortality rates per 100,000 population died from the specified cancer sites

Rationale for measurement: Data and metrics regarding age-standardized mortality rates are needed to provide an accurate measure of the burden of disease across Canada.

Measurement timeframe: Years 1992 to 2014

Denominator: Canadian population estimates by year, sex and age group

Numerator: Number of deaths in the measure timeframe from the specified cancers

Exclusion criteria: For breast cancer, males were excluded

Data availability: All provinces and territories

Stratification:

By cancer site: prostate, lung, breast (female), colorectal

By sex if applicable

By year

Data sources: Statistics Canada, Vital Statistics Death Database

Data retrieval date: December 2017

Variables details:

Up to the year 1999, the cause of deaths from invasive cancer sites/types were defined in ICD-9:

Prostate: 185

Lung: 162

Breast (female): 174

Colorectal: 153-154

After the year 1999, the cause of deaths from invasive cancer sites/types were defined in ICD-10:

Prostate: C61.9

Lung: C34

Breast: C50

Colorectal: C18, C19.9, C20.9, C26.0

Notes from jurisdictions: Not applicable

Methodology notes:

Data presented were jurisdictions combined for ages 0+.

The cause of death from cancer sites/types were classified by World Health Organization, International Classification of Diseases (ICD). Up to the year 1999, the Ninth Edition (ICD-9) was used. After the year 1999, the Tenth Edition (ICD-10) was used.

Mortality rates were age standardized to the Canadian 2011 population using direct method.

Changes to definition compared to previous years: Not applicable

Cancer incidence

Definition: Age-standardized incidence rates per 100,000 population diagnosed for the specified cancer sites

Rationale for measurement: Data and metrics regarding age-standardized incidence rates and trends are needed to provide an accurate measure of the burden of disease across Canada.

Measurement timeframe: Years 1992 to 2013

Denominator: Canadian population estimates by year, sex and age group

Numerator: Number of new invasive cases for the specified cancers diagnosed in the measure timeframe

Exclusion criteria: For breast cancer, males were excluded

Data availability: Data were aggregated at national level:

All provinces and territories, except QC which 2010 data have been copied forward to 2011, 2012 and 2013.

Stratification: Data were aggregated at national level:

By cancer site: prostate, lung, breast (female), colorectal

By sex if applicable

By year

Data source: Statistics Canada, Canadian Cancer Registry (CANSIM table 103-0554

Data retrieval date: October 2017

Variables details: The cancer sites/types were defined in ICD-O3 with behavior code 3 (invasive):

Prostate: 9

Lung: C34

Breast: C50

Colorectal: C18, C19.9, C20.9, C26.0

Cancer cases with histology types 9590-9992 (leukemia, lymphoma and multiple myeloma), 9050-9055 (mesothelioma) and 9140 (Kaposi sarcoma) are excluded.

Notes from jurisdictions: Not applicable

Methodology notes:

Data presented were jurisdictions combined for ages 0+.

The cancer incidence sites/types were classified by World Health Organization, International Classification of Diseases for Oncology, Third Edition (ICD- O-3). The International Agency for Research on Cancer (IARC) rules were used for determining multiple primaries sites.

QC incidence data were not available for 2011 onward, incidence cases and population data in 2010 were copied forward to 2011, 2012 and 2013

Incidence rates were age standardized to the Canadian 2011 population using direct method.

Changes to definition compared to previous years: Not applicable
Related indicators

Related Indicators

Smoking prevalence

Percentage of Canadians ( aged >=12) who reported smoking daily or occasionally, Canada — from 2001 to 2015-16 reporting years

View this indicator

Smoking cessation

Percentage of recent smokers (aged ≥ 20) reporting quitting smoking in the past two years, by age group and by sex, Canada — 2014 reporting year

Show Confidence Intervals - Figure 1.5

View this indicator

Second-hand smoke exposure

Percentage of non-smokers (aged ≥ 12) reporting second-hand smoke exposure, by setting and age group, Canada — 2014 reporting year

Show Confidence Intervals - Figure 1.8

View this indicator

Resection rates for stage II or III rectal cancer, stage III colon cancer and stage II or IIIA non–small cell lung cancer patients

Percentage of Stage II or IIIA non-small cell lung cancer patients who had a surgical resection^†, by province — from 2009 to 2012 diagnosis years

Show Confidence Intervals - Figure 4.4

View this indicator

Post-operative chemotherapy for patients with stage II or IIIA non-small cell lung cancer

Percentage of patients with Stage II or IIIA non-small cell lung cancer who received chemotherapy following surgical resection, by age group, jurisdictions combined^† — 2011 to 2014 diagnosis years

Show Confidence Intervals - Figure 4.28

View this indicator

Geographic variation in lung cancer risk

Geographic variation in smoking prevalence and lung cancer incidence – latest reporting years

^† Smoking rates from each province and territory were divided into tertiles to generate groups of lower, middle and higher risk.

^‡ For incidence rates for territories, years 2012 to 2014 were combined.

QC: cancer incidence data are not available for diagnosis years after 2010. The 2010 Quebec incidence and population data have been copied forward to 2014 for the calculation.

Data sources: Statistics Canada: Canadian Cancer Registry, Canadian Community Health Survey.

View this indicator

Index

Charts and Tables

Figure 8.5

Incidence and mortality rates^† for lung cancer, by sex, Canada — from 1992 to 2014

Figure

Data Table

Data Table

Figure 8.8

Incidence rates for lung cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

Figure

Data Table

Data Table

Data specifications

Cancer deaths

Cancer incidence

Other related sites:

Questions about cancer?

Index

Lung cancer incidence and mortality rates

Charts and Tables

Figure 8.5

Incidence and mortality rates† for lung cancer, by sex, Canada — from 1992 to 2014

Figure

Data Table

Data Table

Figure 8.8

Incidence rates for lung cancer, by stage at diagnosis and province, age-standardized to the 2011 Canadian population — 2015 diagnosis year

Figure

Data Table

Data Table

Data specifications

Cancer deaths

Cancer incidence

Related Indicators

Other related sites:

Questions about cancer?

Incidence and mortality rates^† for lung cancer, by sex, Canada — from 1992 to 2014